Current research toward optimizing dosing of first-line antituberculosis treatment

od McIlleron, Helen, Chirehwa, Maxwell T
Izdano u Expert Rev Anti Infect Ther (2018)

Quantitative assessment of the activity of antituberculosis drugs and regimens

od Chirehwa, Maxwell T., Velásquez, Gustavo E., Gumbo, Tawanda, McIlleron, Helen
Izdano u Expert Rev Anti Infect Ther (2019)

Use of the ‘Accountability for Reasonableness’ Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country

od Moosa, Mohammed Rafique, Maree, Jonathan David, Chirehwa, Maxwell T., Benatar, Solomon R.
Izdano u PLoS One (2016)

Correction: Use of the 'Accountability for Reasonableness' Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country

od Moosa, Mohammed Rafique, Maree, Jonathan David, Chirehwa, Maxwell T., Benatar, Solomon R.
Izdano u PLoS One (2016)

Quality of abstracts of pilot trials in heart failure: A protocol for a systematic survey

od Isiguzo, Godsent, Zunza, Moleen, Chirehwa, Maxwell, Mayosi, Bongani M., Thabane, Lehana
Izdano u Contemp Clin Trials Commun (2017)

Renal abnormalities among HIV-infected, antiretroviral naive children, Harare, Zimbabwe: a cross-sectional study

od Dondo, Vongai, Mujuru, Hilda A, Nathoo, Kusum J, Chirehwa, Maxwell, Mufandaedza, Zivanai
Izdano 2013

Quality of pilot trial abstracts in heart failure is suboptimal: a systematic survey

od Isiguzo, Godsent C., Zunza, Moleen, Chirehwa, Maxwell, Mayosi, Bongani M., Thabane, Lehana
Izdano u Pilot Feasibility Stud (2018)

Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction

od Chirehwa, Maxwell T., Rustomjee, Roxana, Mthiyane, Thuli, Onyebujoh, Philip, Smith, Peter, McIlleron, Helen, Denti, Paolo
Izdano u Antimicrob Agents Chemother (2015)

Erratum for Chirehwa et al., Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction

od Chirehwa, Maxwell T., Rustomjee, Roxana, Mthiyane, Thuli, Onyebujoh, Philip, Smith, Peter, McIlleron, Helen, Denti, Paolo
Izdano u Antimicrob Agents Chemother (2016)

Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis

od Chirehwa, Maxwell T., McIlleron, Helen, Rustomjee, Roxana, Mthiyane, Thuli, Onyebujoh, Philip, Smith, Peter, Denti, Paolo
Izdano u Antimicrob Agents Chemother (2017)

Assessment of quality of obstetric care in Zimbabwe using the standard primipara

od Guzha, Bothwell Takaingofa, Magwali, Thulani Lesley, Mateveke, Bismark, Chirehwa, Maxwell, Nyandoro, George, Munjanja, Stephen Peter
Izdano u BMC Pregnancy Childbirth (2018)

HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients

od Rockwood, Neesha, Meintjes, Graeme, Chirehwa, Maxwell, Wiesner, Lubbe, McIlleron, Helen, Wilkinson, Robert J., Denti, Paolo
Izdano u Antimicrob Agents Chemother (2016)

Effect of efavirenz-based antiretroviral therapy and high-dose rifampicin on the pharmacokinetics of isoniazid and acetyl-isoniazid

od Chirehwa, Maxwell T, McIlleron, Helen, Wiesner, Lubbe, Affolabi, Dissou, Bah-Sow, Oumou, Merle, Corinne, Denti, Paolo
Izdano u J Antimicrob Chemother (2019)

Pharmacokinetics and other risk factors for kanamycin-induced hearing loss in patients with multi-drug resistant tuberculosis

od Ghafari, Nazanin, Court, Richard, Chirehwa, Maxwell Tawanda, Wiesner, Lubbe, Petersen, Lucretia, Maartens, Gary, Gumbo, Tawanda, McIlleron, Helen, Ramma, Lebogang
Izdano u Int J Audiol (2019)

Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis

od Court, Richard, Centner, Chad M., Chirehwa, Maxwell, Wiesner, Lubbe, Denti, Paolo, de Vries, Nihal, Harding, Joseph, Gumbo, Tawanda, Maartens, Gary, McIlleron, Helen
Izdano u Int J Infect Dis (2021)

Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB

od Naidoo, Anushka, Chirehwa, Maxwell, McIlleron, Helen, Naidoo, Kogieleum, Essack, Sabiha, Yende-Zuma, Nonhlanhla, Kimba-Phongi, Eddy, Adamson, John, Govender, Katya, Padayatchi, Nesri, Denti, Paolo
Izdano u J Antimicrob Chemother (2017)

Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone

od Chirehwa, Maxwell T., Court, Richard, de Kock, Mariana, Wiesner, Lubbe, de Vries, Nihal, Harding, Joseph, Gumbo, Tawanda, Maartens, Gary, Warren, Rob, Denti, Paolo, McIlleron, Helen
Izdano u Antimicrob Agents Chemother (2020)

Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis

od Naidoo, Anushka, Ramsuran, Veron, Chirehwa, Maxwell, Denti, Paolo, McIlleron, Helen, Naidoo, Kogieleum, Yende-Zuma, Nonhlanhla, Singh, Ravesh, Ngcapu, Sinaye, Chaudhry, Mamoonah, Pepper, Michael S, Padayatchi, Nesri
Izdano u Pharmacogenomics (2018)

Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis

od Naidoo, Anushka, Chirehwa, Maxwell, Ramsuran, Veron, McIlleron, Helen, Naidoo, Kogieleum, Yende-Zuma, Nonhlanhla, Singh, Ravesh, Ncgapu, Sinaye, Adamson, John, Govender, Katya, Denti, Paolo, Padayatchi, Nesri
Izdano u Pharmacogenomics (2019)

Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus‐associated tuberculosis

od Schutz, Charlotte, Chirehwa, Maxwell, Barr, David, Ward, Amy, Janssen, Saskia, Burton, Rosie, Wilkinson, Robert J., Shey, Muki, Wiesner, Lubbe, Denti, Paolo, McIlleron, Helen, Maartens, Gary, Meintjes, Graeme
Izdano u Br J Clin Pharmacol (2020)